Trials / Sponsors / SparX Biotech(Jiangsu) Co., Ltd.
SparX Biotech(Jiangsu) Co., Ltd.
Academic / Other · 2 registered clinical trials — 1 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Recruiting | A Study of SPX-303, a Bispecific Antibody Targeting LILRB2 and PD-L1 in Patients With Solid Tumors Solid Tumor, HNSCC, RCC | Phase 1 | 2024-03-20 |
| Withdrawn | Study of SPX-101 in Subjects With Advanced or Refractory Solid Tumors Solid Tumors | Phase 1 | 2022-05-01 |